Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 202100 / DOSAGE - FOR SUSPENSION, EXTENDED RELEASE;ORAL - 5MG/ML
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| METHYLPHENIDATE HYDROCHLORIDE(UNII: 4B3SC438HI) (METHYLPHENIDATE - UNII:207ZZ9QZ49) | METHYLPHENIDATE HYDROCHLORIDE | 750mg in 150 | 900mg in 180 | 600mg in 120 | 300mg in 60 |
Inactive Ingredients
| Ingredient Name | NextWave Pharmaceuticals, Inc |
|---|---|
| ANHYDROUS CITRIC ACID(XF417D3PSL) | |
| ANHYDROUS TRISODIUM CITRATE(RS7A450LGA) | |
| POLOXAMER 188(LQA7B6G8JG) | |
| POLYVINYL ACETATE PHTHALATE(58QVG85GW3) | |
| POVIDONE, UNSPECIFIED(FZ989GH94E) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| SODIUM BENZOATE(OJ245FE5EU) | |
| SODIUM POLYSTYRENE SULFONATE(1699G8679Z) | |
| STARCH, CORN(O8232NY3SJ) | |
| SUCRALOSE(96K6UQ3ZD4) | |
| SUCROSE(C151H8M554) | |
| TALC(7SEV7J4R1U) | |
| TRIACETIN(XHX3C3X673) | |
| XANTHAN GUM(TTV12P4NEE) |
